Anfield Capital Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Anfield Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$9.9 - $12.43 $6,276 - $7,880	634 Added 35.24%	2,433 $30,000
Q3 2022 Nov 09, 2022	BUY	$10.14 - $12.38 $588 - $718	58 Added 3.33%	1,799 $19,000
Q2 2022 Aug 09, 2022	BUY	$11.05 - $12.72 $2,563 - $2,951	232 Added 15.37%	1,741 $20,000
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $8,753 - $10,626	825 Added 120.61%	1,509 $19,000
Q4 2021 Feb 03, 2022	BUY	$10.86 - $13.95 $6,874 - $8,830	633 Added 1241.18%	684 $8,000
Q3 2021 Nov 04, 2021	BUY	$11.92 - $13.92 $607 - $709	51 New	51 $1,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.